I read with great interest the case report by Kumar et al. [1] published in the October-December 2018 issue of the Journal of Applied Hematology. The authors reported a 6-month-old Indian child with persistent diarrhea, growth retardation, irritability, anorexia, anemia, and hepatosplenomegaly due to Vitamin B12 deficiency that responded to Vitamin B12 treatment. [1] The authors attributed that Vitamin B12 deficiency to the observation that the studied infant was exclusively breastfed without complementary feeds. However, they did not attempt to evaluate Vitamin B12 status in the mother and its correlation with Vitamin B12 status in her infant. The issue of Vitamin B12 deficiency in Indian infants and their mothers is really a matter of concern. Interestingly, the prevalence of Vitamin B12 deficiency in exclusively breastfed Indian infants aged 1-6 months infants was found to be alarmingly high (57%), while 46% of their mothers were deficient. There was a positive correlation between the Vitamin B12 levels of the infants and their mothers. [2] Hence, I assume that measuring serum Vitamin B12 in the mother of the studied infant was solicited. The case in question sent an important message to the practicing pediatricians to consider underlying Vitamin B12 deficiency in any infant presenting with protean manifestations. Although periconceptional folate supplementation is globally recommended and practiced, Vitamin B12 supplementation during early gestation and lactation has received little consideration, particularly in the developing countries. [3] I assume that the case in question sent additional sound message to the policy makers in India to take into consideration routine Vitamin B12 supplementation during early pregnancy and lactation to contain the burden and serious consequences of Vitamin B12 deficiency in pregnant and their infants.
